Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Baxter International Inc (NYSE:BAX)

44.01
Delayed Data
As of Dec 02
 +0.38 / +0.87%
Today’s Change
34.06
Today|||52-Week Range
50.16
+15.36%
Year-to-Date
BAX Regular Dividend: BAX began trading ex-dividend on 11/30/16. A $0.13 dividend will be paid to shareholders of record as of 12/02/16.
Medtronic Introduces CoreValve Evolut R System in Japan
Dec 02 / Zacks.com - Paid Partner Content
Medtronic's Less-Invasive HVAD Implant System Gets CE Mark
Nov 30 / Zacks.com - Paid Partner Content
Omnicell to Buy Ateb, Expand in Adherence Tools Market
Dec 02 / Zacks.com - Paid Partner Content
Baxter (BAX) Inks Partnership with Americares, Stock Down
Nov 30 / Zacks.com - Paid Partner Content
Neogen (NEOG) to Buy Quat-Chem, Shares Hit 52-Week High
Dec 02 / Zacks.com - Paid Partner Content
Edward Lifesciences (EW) to Buy Israel's Valtech Cardio
Nov 29 / Zacks.com - Paid Partner Content
Medtronic Stock Falls on Mixed 2Q; Positive on HeartWare Buy
Dec 02 / Zacks.com - Paid Partner Content
NuVasive: Q3 Results Lack Shine, Spine Market Holds Promise
Nov 29 / Zacks.com - Paid Partner Content
Medtronic Partners UH to Launch Integrated Health Solutions
Dec 01 / Zacks.com - Paid Partner Content
Walgreen Boots: Mixed Q4, Awaits Rite Aid Deal Closure
Nov 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close43.63
Today’s open43.78
Day’s range43.69 - 44.20
Volume5,933,939
Average volume (3 months)4,191,689
Market cap$23.9B
Dividend yield1.18%
Data as of 4:01pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)-61.40%
Earnings growth (this year)+38.26%
Earnings growth (next 5 years)+11.00%
Revenue growth (last year)-40.20%
P/E ratio4.9
Price/Sales2.10
Price/Book2.72

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.06-0.12%
ALXNAlexion Pharmaceutic...+0.95+0.78%
VRTXVertex Pharmaceutica...-2.32-2.98%
MYLMylan NV-0.04-0.11%
Data as of 4:14pm ET, 12/02/2016

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$0.52
Annual revenue (last year)$10.0B
Annual profit (last year)$968.0M
Net profit margin3.94%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Joe Almeida
Vice President-
Operations
Scott Pleau
Corporate headquarters
Deerfield, Illinois

Forecasts


Search for Jobs